Zydus gets USFDA nod for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day Read more
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients with comorbidities Read more
Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management 2023 Read more
Zydus gets USFDA approval for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg Read more